Pathological complete response to neoadjuvant alectinib in unresectable anaplastic lymphoma kinase positive non-small cell lung cancer: A case report

doi:10.12998/wjcc.v11.i22.5322

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2804)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1371

Figures (1-3)

371

Tables (1-1)

291

Sum=2098

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

137

Download

441

Sum=578

Aug 6, 2023 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 6, 2023; 11(22): 5322-5328
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5322

Full Size Figure Download Figure

Figure 3 Positron emission tomography computed tomography images after alectinib treatment demonstrating partial remission. A: Compared to baseline; B: The primary lesion has shrunk and the enlarged lymph nodes have almost disappeared after 14 mo of treatment. Positron emission tomography computed tomography, positron emission tomography-computed tomography.

Citation: Wang LM, Zhao P, Sun XQ, Yan F, Guo Q. Pathological complete response to neoadjuvant alectinib in unresectable anaplastic lymphoma kinase positive non-small cell lung cancer: A case report. World J Clin Cases 2023; 11(22): 5322-5328
URL: https://www.wjgnet.com/2307-8960/full/v11/i22/5322.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i22.5322